Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,036 Brain Cancer
clinical trials

Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sutter Auburn Faith Hospital
mi
from
Auburn, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Rush - Copley Medical Center
mi
from
Aurora, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Kirklin Clinic at Acton Road
mi
from
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sutter Cancer Centers Radiation Oncology Services-Cameron Park
mi
from
Cameron Park, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Luke's Hospital
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Miami Valley Hospital South
mi
from
Centerville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
John H. Stroger, Jr. Hospital of Cook County
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Cleveland Clinic Cancer Center at Fairview Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Carle on Vermilion
mi
from
Danville, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Miami Valley Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Pocono Medical Center
mi
from
East Stroudsburg, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Cancer Center-Elyria
mi
from
Elyria, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Bay Area Breast Surgeons Inc
mi
from
Emeryville, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Genesys Hurley Cancer Institute
mi
from
Flint, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Parkview Hospital Randallia
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Dayton Physicians LLC-Atrium
mi
from
Franklin, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Fredericksburg Oncology Inc
mi
from
Fredericksburg, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Unity Hospital
mi
from
Fridley, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Health Saint Mary's
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Green Bay Oncology at Saint Vincent Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Legacy Mount Hood Medical Center
mi
from
Gresham, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
UW Cancer Center Johnson Creek
mi
from
Johnson Creek, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
North Kansas City Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Medical Center - Las Cruces
mi
from
Las Cruces, NM
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Kansas Institute of Medicine Cancer and Blood Center
mi
from
Lenexa, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Liberty Radiation Oncology Center
mi
from
Liberty, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Covenant Medical Center-Lakeside
mi
from
Lubbock, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint John's Hospital - Healtheast
mi
from
Maplewood, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Carle Physician Group-Mattoon/Charleston
mi
from
Mattoon, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Summa Health Center at Lake Medina
mi
from
Medina, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Palo Alto Medical Foundation-Gynecologic Oncology
mi
from
Mountain View, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Alta Bates Summit Medical Center - Summit Campus
mi
from
Oakland, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Charles Hospital
mi
from
Oregon, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Luke's South Hospital
mi
from
Overland Park, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Michiana Hematology Oncology
mi
from
Plymouth, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Mercy Oakland
mi
from
Pontiac, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Renown Regional Medical Center
mi
from
Reno, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Highland Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Heartland Regional Medical Center
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Oncology, Inc.
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Siteman Cancer Center-South County
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Park Nicollet Clinic - Saint Louis Park
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Regions Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Palo Alto Medical Foundation-Santa Cruz
mi
from
Santa Cruz, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Iredell Memorial Hospital
mi
from
Statesville, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Cleveland Clinic Cancer Center-Strongsville
mi
from
Strongsville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Vincent Mercy Medical Center
mi
from
Toledo, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Munson Medical Center
mi
from
Traverse City, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Upper Valley Medical Center
mi
from
Troy, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Warren Clinic Oncology-Tulsa
mi
from
Tulsa, OK
Click here to add this to my saved trials
Neoplasms, Brain Clinical Trial
A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects
Status: Enrolling, Phase I
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Neoplasms, Brain Clinical Trial
A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects
Status: Enrolling, Phase I
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM)
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM)
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Rockville Centre
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Brain Metastasis Clinical Trial
IDO2 Genetic Status Informs the Neoadjuvant Efficacy of Chloroquine (CQ) in Brain Metastasis Radiotherapy
Status: Enrolling
Updated: 11/15/2012
Lankenau Medical Center
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Oncology Clinical Trial
AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 1/16/2013
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospitals and Clinics - Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
Status: Enrolling, Phase II
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
Status: Enrolling, Phase II
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Oncology Clinical Trial
PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
Status: Enrolling, Phase II
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 1/11/2013
National Cancer Institute Neuro-Oncology Branch
mi
from
Bethesda, MD
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Lehigh Valley Hospital - Muhlenberg
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence Portland Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence Regional Cancer System-Aberdeen
mi
from
Aberdeen, WA
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
AnMedical Health Cancer Center
mi
from
Anderson, SC
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Mission Hospital-Memorial Campus
mi
from
Asheville, NC
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Billings Clinic Cancer Center
mi
from
Billings, MT
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center-Boise
mi
from
Boise, ID
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Highline Medical Center-Main Campus
mi
from
Burien, WA
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical Oncology and Hematology Associates-West Des Moines
mi
from
Clive, IA
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Cancer Centers-Penrose
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Ellis Fischel Cancer Center
mi
from
Columbia, MO
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Illinois CancerCare - Eureka
mi
from
Eureka, IL
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Genesys Hurley Cancer Institute
mi
from
Flint, MI
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Aurora Health Center-Fond du Lac
mi
from
Fond Du Lac, WI
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Center of Kansas - Fort Scott
mi
from
Fort Scott, KS
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente - Gaithersburg Medical Center
mi
from
Gaithersburg, MD
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Adams Cancer Center
mi
from
Gettysburg, PA
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Altru Cancer Center
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Research Consortium of West Michigan NCORP
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Greenville Health System Cancer Institute-Faris
mi
from
Greenville, SC
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Greenville Health System Cancer Institute/Eastside
mi
from
Greenville, SC
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Greenville Memorial Hospital
mi
from
Greenville, SC
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Legacy Mount Hood Medical Center
mi
from
Gresham, OR
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Cherry Tree Cancer Center
mi
from
Hanover, PA
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer and Blood Specialists-Henderson
mi
from
Henderson, NV
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
New Hampshire Oncology - Hematology, PA - Hooksett
mi
from
Hooksett, NH
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
CHI Health Good Samaritan
mi
from
Kearney, NE
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Wellmont Medical Associates Oncology and Hematology-Kingsport
mi
from
Kingsport, TN
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence Regional Cancer System-Lacey
mi
from
Lacey, WA
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
HealthCare Partners Medical Group Oncology/Hematology-San Martin
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling, Phase III
Updated: 12/31/1969
Radiation Oncology Centers of Nevada Southeast
mi
from
Las Vegas, NV
Click here to add this to my saved trials
1 … 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 … 100